Weighing in before the fight - Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy

被引：35
|
作者：
Denke, MA [1 ]
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
来源：
CIRCULATION | 2005年 / 112卷 / 22期
关键词：
editorials; cholesterol; lipoproteins; patients;
D O I：
10.1161/CIRCULATIONAHA.105.588178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3368 / 3370
页数：3
相关论文
共 50 条
  • [21] Apolipoprotein B and Non-High-Density Lipoprotein Cholesterol Are Better Risk Markers for Coronary Artery Disease than Low-Density Lipoprotein Cholesterol in Hypertriglyceridemic Metabolic Syndrome Patients
    Boumaiza, Imen
    Omezzine, Asma
    Rejeb, Jihene
    Rebhi, Lamia
    Kalboussi, Nesrine
    Ben Rejeb, Nabila
    Nabli, Naoufel
    Ben Abdelaziz, Ahmed
    Boughazala, Essia
    Bouslama, Ali
    METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (06) : 515 - 522
  • [22] Apolipoprotein B versus non-high-density lipoprotein cholesterol - And the winner is...
    Sniderman, AD
    CIRCULATION, 2005, 112 (22) : 3366 - 3367
  • [23] Fasting non-high-density lipoprotein cholesterol and low-density lipoprotein particle size
    Arisaka, Osamu
    Kariya, Katsura
    Ichikawa, Go
    JOURNAL OF PEDIATRICS, 2012, 160 (03): : 531 - 532
  • [24] Total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol in atherosclerosis cardiovascular disease and cancer in Chinese male
    Guan, X. M.
    Yang, X. L.
    Han, X.
    Yang, Y. H.
    Liu, Y.
    Li, H. H.
    Zhan, S. Y.
    Wu, S. L.
    Xia, Y. L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 724 - 725
  • [25] Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction
    Farwell, WR
    Sesso, HD
    Buring, JE
    Gaziano, JM
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (08): : 1129 - 1134
  • [26] Relationship between non-high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
    Li, Ya
    Li, Shu
    Ma, Yulin
    Li, Jialing
    Lin, Mingying
    Wan, Jing
    CORONARY ARTERY DISEASE, 2020, 31 (07) : 623 - 627
  • [27] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Liliana Fonseca
    Sílvia Paredes
    Helena Ramos
    José Carlos Oliveira
    Isabel Palma
    Lipids in Health and Disease, 19
  • [28] Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol
    Fonseca, Liliana
    Paredes, Silvia
    Ramos, Helena
    Oliveira, Jose Carlos
    Palma, Isabel
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [29] Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
    Sniderman, Allan
    McQueen, Matt
    Contois, John
    Williams, Ken
    Furberg, Curt D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (03) : 152 - 155
  • [30] Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy
    Frost, PH
    Havel, RJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A): : 26B - 31B
12345